Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 8,000 shares at $14.60 ($117K) on 2026-05-05, disclosed to the SEC on 2026-05-06.
Scheduled sale ($117k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.60 | 7,800 | $114K | 97.3% |
| 2 | $15.58 | 200 | $3K | 2.7% |
| Total | $14.62 avg | 8,000 | $117K | 100% |
| Filing → |
| CGEM | SELL | 2026-07-07 | $143K | — | Filing → |
| CGEM | SELL | 2026-03-09 | $125K | — | Filing → |
| CGEM | SELL | 2026-02-26 | $25K | — | Filing → |